Artificial intelligence technologies have long held promise for revolutionizing the path to drug discovery and better health outcomes. Recently, large language models and other artificial intelligence technologies have begun to structure and take advantage of abundant but previously unusable biological data to deliver on this promise. Join this session for a candid conversation about how the tech, business, and legal worlds are collaborating to enable this new paradigm for healthcare outcomes.